Intelligent Medicine Exchange

Hedge the Healthcare
Economy — with IMX

About IMX

Healthcare needs access to the same capital market tools available in other sectors of the economy.

IMX's mission is to develop the space for a wide user-base to create and hedge exposure to a broad range of healthcare risks.

IMX is the first derivatives marketplace focused on the healthcare industry. We aim to deliver contracts that will enable market participants to effectively manage risk and explore investment opportunities across various components of the healthcare ecosystem.

Approach

We're creating a new paradigm - designing tailored derivative contracts, integrating existing indices, and utilizing big data and AI to fuel research and insights into the healthcare sector.

Our two-sided marketplace allows participants to hedge risk and invest in a new asset class.

Investment Managers

Build portfolio resilience and alpha generation opportunities.

Insurance Providers

Hedge unpredictable healthcare expenses and develop more accurate pricing.

Pharmaceutical & Biotech

Hedge costs across R&D phases and mitigate supply chain disruptions.

Healthcare Systems

Defray risk of rising treatment costs and fluctuations in frequency of procedures.

Global Banks & Brokerage Firms

Offer new risk management solutions to healthcare clients.

Market Makers

Expand market reach and provide liquidity in a new venue.

Investment Managers

Build portfolio resilience and alpha generation opportunities.

Global Banks & Brokerage Firms

Offer new risk management solutions to healthcare clients.

Market Makers

Expand market reach and provide liquidity in a new venue.

Healthcare Systems

Defray risk of rising treatment costs and fluctuations in frequency of procedures.

Insurance Providers

Hedge unpredictable healthcare expenses and develop more accurate pricing.

Pharmaceutical & Biotech

Hedge costs across R&D phases and mitigate supply chain disruptions.

Latest News & Insights

Discover more from IMX and read up on the latest research on the healthcare industry.

CFTC Approves Intelligent Medicine Exchange^TM (IMX) as New Futures Exchange

In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.

Everything to Know About Healthcare’s First Futures Trading Exchange

In the rapidly evolving landscape of the pharmaceutical industry, data emerges as the next blockbuster, reshaping the way healthcare operates. As companies increasingly harness the power of big data, transformative insights pave the way for personalized medicine.

First Exchange Focused on Risk in the Health Care Economy

Increasingly, a significant number of Americans are opting to forgo essential healthcare services, navigating a landscape marred by the daunting uncertainty of associated costs.

CFTC Designates IMX Health, LLC as a Contract Market

In the rapidly evolving landscape of the pharmaceutical industry, data emerges as the next blockbuster, reshaping the way healthcare operates. As companies increasingly harness the power of big data, transformative insights pave the way for personalized medicine.

New Futures Exchange Offers Hedge Against Health-Care Costs

In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.

Health Care Gets Commodity Treatment with First Futures Exchange

In the rapidly evolving landscape of the pharmaceutical industry, data emerges as the next blockbuster, reshaping the way healthcare operates. As companies increasingly harness the power of big data, transformative insights pave the way for personalized medicine.

Morningstar Indexes Selected by IMX Health for First Healthcare Futures Exchange Product Offering

Increasingly, a significant number of Americans are opting to forgo essential healthcare services, navigating a landscape marred by the daunting uncertainty of associated costs.

In the rapidly evolving landscape of the pharmaceutical industry, data emerges as the next blockbuster, reshaping the way healthcare operates. As companies increasingly harness the power of big data, transformative insights pave the way for personalized medicine.

In a concerning trend, a growing number of older adults find themselves compelled to make agonizing choices, sacrificing fundamental necessities to cope with the escalating burden of healthcare costs.

Thanks for signing up to our newsletter.

Please enter a valid email address.

Intelligent Medicine Exchange^™ is a Designated Contract Market registered with the U.S. Commodity Futures Trading Commission. The information in this text should be considered general information and not in any case as a recommendation or advice concerning investment decisions. The reader itself is responsible for the risks associated with an investment decision based on the information stated in this material in light of his or her specific circumstances.

The information on this website is for informational purposes only, and does not contend to address the financial objectives, situation, or specific needs of any individual investor. Trading in derivatives and other financial instruments involves risk.

© 2024 Intelligent Medicine Exchange

Terms and Conditions

/